NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE16499 Query DataSets for GSE16499
Status Public on Jan 11, 2010
Title Heart Failure Associated Changes in Alternative Splicing of Sarcomere Genes
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Alternative mRNA splicing is an important mechanism for regulation of gene expression. Changes in gene expression contribute to the pathogenesis of heart failure. However, changes in mRNA splicing have not been systematically examined in heart disease. We hypothesized that mRNA splicing is changed in diseased hearts.
We used the Affymetrix exon array, which separately measures expression of each known and computationally predicted exon, to globally evaluate changes in mRNA splicing in left ventricular myocardial RNA from control and ischemic cardiomyopathy (ICM) patients. We found that mRNA splicing is systematically changed in heart failure. RTPCR validated 9 previously unreported alternative splicing events. Furthermore, we demonstrated that the splicing of four key sarcomere genes, cardiac troponin T (TNNT2), cardiac troponin I (TNNI3), myosin heavy chain 7 (MYH7), and filamin C (FLNC), was significantly altered in ICM. Altered splicing of these genes in heart disease was confirmed in independent ICM samples, and in dilated cardiomyopathy and aortic stenosis. The minor variant fraction of these five genes was sufficient to classify samples into control or disease groups with 95% accuracy.
Our data indicate that alternative splicing is systematically altered in human heart disease, suggesting that disease-associated perturbation of RNA splicing may contribute to the pathogenesis and development of heart failure. Disease-related changes in splicing of sarcomere genes may directly impact cardiomyocyte function.
 
Overall design 15 ischemic heart failure samples and 15 age and sex matched control heart samples were collected. Left ventricular myocardial samples, remote from infarcted areas, were obtained from explanted ischemic cardiomyopathy hearts at the time of transplantation, and from unused transplant donor hearts. Diseased hearts had ejection fraction < 40% and/or New York State Heart Association class III or class IV heart failure.
 
Contributor(s) Kong SW, Pu WT
Citation(s) 20124440
Submission date Jun 08, 2009
Last update date Feb 18, 2019
Contact name Sek Won Kong
E-mail(s) swkong@enders.tch.harvard.edu
Phone 617-919-2689
Organization name Boston Children's Hospital
Department Informatics Program
Lab EN137
Street address 300 Longwood Avenue
City Boston
State/province MA
ZIP/Postal code 02115
Country USA
 
Platforms (1)
GPL5175 [HuEx-1_0-st] Affymetrix Human Exon 1.0 ST Array [transcript (gene) version]
Samples (30)
GSM414642 Normal left ventricular function, Left Ventricle, sample 1
GSM414643 Normal left ventricular function, Left Ventricle, sample 2
GSM414644 Normal left ventricular function, Left Ventricle, sample 3
Relations
BioProject PRJNA116119

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE16499_RAW.tar 556.6 Mb (http)(custom) TAR (of CEL)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap